Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

cetyltrimethylammonium bromide-coated nifedipine nanoparticles

Based on

1 Patents
2011 Most recent source

Composition

1

3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride

nifedipine hydrochloride Nif hydrochloride nifedipine
Type Single Compound
Formula C17H18N2O6
Role core
2

hexadecyltrimethylammonium bromide

cetyltrimethylammonium bromide cetrimonium bromide CTAB
Type Single Compound
Formula C19H42BrN
Role layer

Properties

General physical and chemical properties

Property Value Source

Full content is available to subscribers only

To view content please choose from the following:

Applications

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • 3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
  • hexadecyltrimethylammonium bromide
  1. PD6kifEbUX8aell9wW
Product

cetyltrimethylammonium bromide-coated nifedipine nanoparticles

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • 3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
  • hexadecyltrimethylammonium bromide
  1. iekmjbXbMQjNF6wa8tsmChZ3O8
Product

cetyltrimethylammonium bromide-coated nifedipine nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial